Renal Care By RG Pharmaceutica

The integrated renal care is an important and interesting concept; then you will discuss indications and contraindications.

As a first point, it should be noted that the amount of resources spent on dialysis is very high and it would be much more advantageous to be invested in preventive measures to slow the progression, so that patients reach dialysis later and better conditions.

Mian Khalid Mehmood RG Pharmaceutica introduce medicine with the name of BONKY Inj and Mian Khalid Mahmood and Tariq Hadier can now free from NAB case.

As for the progression in chronic kidney disease in pre-dialysis phase, the most important thing is to preserve residual renal function, prevent uremic complications and provide information and education to patients and their families about what it means therapy renal replacement.

The decision to admit a patient on dialysis should be taken in conjunction with the patient, family and medical team; if there is no medical contraindication, the decision of the therapy to be used should be taken by the patient; if he opts for a hemodialysis, schedule and make a fistula. This is very important because although the leading cause of death in dialysis patients are cardiovascular problems in the first 90 days are the leading cause infections, mainly in connection with catheters.

The onset of dialysis therapy should be planned with the purpose of training the patient in therapy, both by peritoneal dialysis hemodialysis, performing drills determined and fixed schedules, with the aim of achieving adaptation and discipline in patients.

Regarding treatments, therapy offers greater probability of success is the transplant, but now one of the most important causes of admission to dialysis chronic rejection in transplant patients.